Trevi Therapeutics (TRVI) PT Raised to $25 at Leerink Partners

April 21, 2026 4:16 AM

Leerink Partners analyst Roanna Ruiz raised the price target on Trevi Therapeutics (NASDAQ: TRVI) to $25.00 (from $21.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found